189
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Recurrent acute myopericarditis without effusion during ATRA induction and ATO salvage of APL: a variant form of the differentiation syndrome?

, , , , , , , , , & show all
Pages 1743-1746 | Received 10 Oct 2016, Accepted 20 Oct 2016, Published online: 06 Dec 2016

References

  • Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 2008;111:2505–2515.
  • de la Serna J, Montesinos P, Vellenga E, et al. Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood. 2008;111:3395–3402.
  • Frankel SR, Eardley A, Lauwers G, et al. The retinoic acid syndrome in acute promyelocytic leukemia. Ann Intern Med. 1992;117:292–296.
  • Testi AM, Biondi A, Lo Coco F, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood. 2005;106:447–453.
  • Sanz MA, Montesinos P, Rayon C, et al. Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome. Blood. 2010;115:5137–5146.
  • Soignet SL, Frankel SR, Douer D, et al. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. J Clin Oncol. 2001;19:3852–3860.
  • Montesinos P, Bergua JM, Vellenga E, et al. Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors. Blood. 2009;113:775–783.
  • Sanz MA, Tallman MS, Lo-Coco F. Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Blood. 2005;105:3019–3025.
  • Kakkar N, Dhameja N, Jasmina, et al. ATRA syndrome with extensive organ infiltration. Am J Hematol. 2002;71:62–64.
  • Fabbiano F, Magrin S, Cangialosi C, et al. All-trans retinoic acid induced cardiac and skeletal myositis in induction therapy of acute promyelocytic leukaemia. Br J Haematol. 2005;129:444–445.
  • Klein SK, Biemond BJ, van Oers MH. Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA). Ann Hematol. 2007;86:917–918.
  • Manna A, Cadenotti L, Motto A, et al. Reversible cardiac dysfunction without myocytolysis related to all-trans retinoic acid administration during induction therapy of acute promyelocytic leukemia. Ann Hematol. 2009;88:91–92.
  • van Rijssel RH, Wegman J, Oud ME, et al. A case of ATRA-induced isolated myocarditis in the absence of circulating malignant cells: demonstration of the t(15;17) translocation in the inflammatory infiltrate by in situ hybridisation. Leuk Res. 2010;34:e142–e144.
  • Isik P, Cetin I, Tavil B, et al. All-transretinoic acid (ATRA) treatment-related pancarditis and severe pulmonary edema in a child with acute promyelocytic leukemia. J Pediatr Hematol Oncol. 2010;32:e346–e348.
  • Choi S, Kim HS, Jung CS, et al. Reversible symptomatic myocarditis induced by all-trans retinoic acid administration during induction treatment of acute promyelocytic leukemia: rare cardiac manifestation as a retinoic acid syndrome. J Cardiovasc Ultrasound. 2011;19:95–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.